Sign In
Buy AMRX
$12.88
+0.225 (+1.78%)
At Close: Jun 03, 2026
AMRX or ZTS: Which Is the Better Value Stock Right Now?
12:46pm, Monday, 10'th May 2021
AMRX vs. ZTS: Which Stock Is the Better Value Option?
Amneal Pharmaceuticals, Inc. (AMRX) CEO Chintu Patel on Q1 2021 Results - Earnings Call Transcript
04:29pm, Friday, 07'th May 2021
Amneal Pharmaceuticals, Inc. (AMRX) CEO Chintu Patel on Q1 2021 Results - Earnings Call Transcript
Amneal Pharmaceuticals (AMRX) Q1 Earnings Beat Estimates
08:16am, Friday, 07'th May 2021
Amneal (AMRX) delivered earnings and revenue surprises of 11.11% and -2.81%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Amneal Reports First Quarter 2021 Financial Results
06:00am, Friday, 07'th May 2021
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) announced its results today for the first quarter ended March 31, 2021. “Amneal delivered solid firs
NEW YORK, April 12, 2021 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty
New York, New York--(Newsfile Corp. - March 31, 2021) - Levi & Korsinsky announces it has commenced an investigation of Amneal Pharmaceuticals, Inc. (NYSE: AMRX) concerning possible breaches of fiduci
A Trio of Small Caps for the Growth-Oriented Investor
11:28am, Wednesday, 31'st Mar 2021
Investors who chase growth could be interested in the following small-cap stocks as they represent companies whose trailing 12-month net earnings per share improved significantly on a year-over-year b
Amneal Pharmaceuticals, Inc. (AMRX) CEO Chintu Patel on Q4 2020 Results - Earnings Call Transcript
03:24pm, Friday, 26'th Feb 2021
Amneal Pharmaceuticals, Inc. (AMRX) CEO Chintu Patel on Q4 2020 Results - Earnings Call Transcript
Amneal Pharmaceuticals (AMRX) Surpasses Q4 Earnings and Revenue Estimates
08:21am, Friday, 26'th Feb 2021
Amneal (AMRX) delivered earnings and revenue surprises of 7.69% and 1.55%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Amneal Receives Approval for Generic Version of Ortho Evra®
06:02am, Friday, 26'th Feb 2021
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (ANDA) approval
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
06:00am, Friday, 26'th Feb 2021
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the "Company") announced its results today for the fourth quarter and full year ended December 31, 2020. "We are extremel
Why Amneal Pharmaceuticals (AMRX) Might Surprise This Earnings Season
09:08am, Thursday, 25'th Feb 2021
Amneal Pharmaceuticals (AMRX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
AMRX or CORT: Which Is the Better Value Stock Right Now?
12:27pm, Wednesday, 10'th Feb 2021
AMRX vs. CORT: Which Stock Is the Better Value Option?
Amneal to Report Fourth Quarter & Full Year 2020 Results on February 26, 2021
08:00am, Thursday, 04'th Feb 2021
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that the Company will release its fourth quarter and full year 2020 financial results on Friday, February
AMRX or PCRX: Which Is the Better Value Stock Right Now?
12:47pm, Friday, 15'th Jan 2021
AMRX vs. PCRX: Which Stock Is the Better Value Option?
